logo

This resource provides data on the human genome and epigenome to facilitate genetic studies of common metabolic disease risk as part of the AMP CMD consortium, which includes the National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) and an international collaboration of academic and industry partners.